{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:45:14Z","timestamp":1755218714996,"version":"3.43.0"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21wm0425019","JP21wm0425018","JP20dm017106"],"award-info":[{"award-number":["JP21wm0425019","JP21wm0425018","JP20dm017106"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP16H06277","JP20K06910","JP23K19565"],"award-info":[{"award-number":["JP16H06277","JP20K06910","JP23K19565"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jns.2025.123596","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T19:06:19Z","timestamp":1750878379000},"page":"123596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Progressive multifocal leukoencephalopathy secondary to idiopathic CD4 lymphocytopenia with balanced CD4\/CD8 inflammation significantly improved after treatment with mirtazapine and mefloquine"],"prefix":"10.1016","volume":"475","author":[{"given":"Lindun","family":"Ge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kadowaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyoshi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goichi","family":"Beck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jns.2025.123596_bb0005","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41582-020-00427-y","article-title":"Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease","volume":"17","author":"Cortese","year":"2021","journal-title":"Nat. Rev. Neurol."},{"issue":"6","key":"10.1016\/j.jns.2025.123596_bb0010","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/neup.12599","article-title":"Progressive multifocal leukoencephalopathy in idiopathic CD4+ lymphocytopenia: a case report and review of literature","volume":"39","author":"Aggarwal","year":"2019","journal-title":"Neuropathology"},{"key":"10.1016\/j.jns.2025.123596_bb0015","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2147\/ITT.S214139","article-title":"Idiopathic CD4 lymphocytopenia: current insights","volume":"9","author":"Vijayakumar","year":"2020","journal-title":"Immunotargets Ther."},{"issue":"385","key":"10.1016\/j.jns.2025.123596_bb0020","article-title":"Progressive multifocal leukoencephalopathy secondary to idiopathic CD4 lymphocytopenia treated with pembrolizumab","volume":"15","author":"Varmpompiti","year":"2023","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.jns.2025.123596_bb0025","first-page":"652","article-title":"Successful treatment of progressive multifocal leukoencephalopathy with recombinant interleukin-7 and maraviroc in a patient with idiopathic CD4 lymphocytopenia","volume":"24","author":"Harel","year":"2018","journal-title":"J. Neuro-Oncol."},{"issue":"1","key":"10.1016\/j.jns.2025.123596_bb0030","article-title":"Long-term prognosis and overall mortality in patients with progressive multifocal leukoencephalopathy","volume":"13","author":"Kim","year":"2023","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.jns.2025.123596_bb0035","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1086\/427698","article-title":"Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy","volume":"40","author":"Bossolasco","year":"2005","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.jns.2025.123596_bb0040","first-page":"351","article-title":"A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes","volume":"19","author":"Clifford","year":"2013","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jns.2025.123596_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2023.120774","article-title":"Epidemiology of progressive multifocal leukoencephalopathy in Japan and effectiveness of mefloquine: a retrospective analysis of a nationwide inpatient database","volume":"453","author":"Otaka","year":"2023","journal-title":"J. Neurol. Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.jns.2025.123596_bb0050","first-page":"25","article-title":"Inflammatory reaction in progressive multifocal leukoencephalopathy: harmful or beneficial?","volume":"9","author":"Du Pasquier","year":"2003","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jns.2025.123596_bb0055","doi-asserted-by":"crossref","first-page":"9200","DOI":"10.1128\/JVI.00609-10","article-title":"JC virus latency in the brain and extraneural organs of patients with and without progressive multifocal leukoencephalopathy","volume":"84","author":"Tan","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.jns.2025.123596_bb0060","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2169\/internalmedicine.55.6051","article-title":"Progressive multifocal leukoencephalopathy with balanced CD4\/CD8 T-cell infiltration and good response to mefloquine treatment","volume":"55","author":"Sanjo","year":"2016","journal-title":"Intern. Med."},{"issue":"11","key":"10.1016\/j.jns.2025.123596_bb0065","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1212\/WNL.0b013e3182a43e6d","article-title":"In situ evidence of JC virus control by CD8+ T cells in PML-IRIS during HIV infection","volume":"81","author":"Martin-Blondel","year":"2014","journal-title":"Neurology"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25002138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25002138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T09:41:35Z","timestamp":1754473295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X25002138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":13,"alternative-id":["S0022510X25002138"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2025.123596","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progressive multifocal leukoencephalopathy secondary to idiopathic CD4 lymphocytopenia with balanced CD4\/CD8 inflammation significantly improved after treatment with mirtazapine and mefloquine","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2025.123596","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123596"}}